Results 81 to 90 of about 16,312 (208)

Hyperphosphatemia in chronic kidney disease [PDF]

, 2019
Hyperphosphatemia in renal pathology is a key factor for developing mineral and bone disorders. It can develop even in the early stages of renal function decline and predict the formation of vascular calcification and an increased risk for developing ...
S. A. Martynov, M. Sh. Shamkhalova
core   +1 more source

Hyperphosphatemia among patients with chronic kidney disease

, 2015
Background: Hyperphosphatemia alone or in combination with hypercalcemia has been associated with increased mortality and morbidity among patients with chronic kidney disease (CKD).
Alizadeh-Atar, Gh.R., Chitsazian, Z., Beladi-Mousavi, S.S., Hayati, F., Shayanpour, Sh.   +4 more
core  

Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice

Chronic kidney disease (CKD) is associated with various pathologic changes, including elevations in serum phosphate levels (hyperphosphatemia), vascular calcification, and skeletal muscle atrophy.
Abul Fajol, Svetlana Komarova, Matthew S. Alexander, Brian Czaya, Jordan Bradley, Glenn C. Rowe, Christian Faul, Seth Bollenbecker, Kylie Heitman, Sarah Madison Thomas, Qing Li, Stefanie Krick   +11 more
core   +1 more source

Massive hyperphosphatemia in a patient with neuronal intestinal dysplasia after bowel preparation with oral sodium phosphate

, 2013
Oral sodium phosphate-based laxatives are frequently used for bowel preparation or relief of constipation in some countries. However, these agents are not without risk.

core   +1 more source

Risk factor analysis and prediction model construction for hyperphosphatemia in uremic patients after dialysis treatment

Linchuang shenzangbing zazhi
ObjectiveTo identify the independent risk factors for hyperphosphatemia in uremic patients after dialysis and to develop a predictive model to guide clinical intervention.MethodsA retrospective analysis was conducted on the clinical data of 155 uremic ...
Zhang Bin-chuan, Liu Kun, Wang Cheng-jun, Zhang Song-tao, Zhu Guan-neng   +4 more
doaj  

Development and validation of a nomogram for predicting hyperphosphatemia in non-dialysis patients with chronic kidney disease

BMC Nephrology
Background Elevated serum phosphate levels are strongly associated with an increased risk of all-cause mortality in patients with chronic kidney disease (CKD).
Xianhui Zhao, Caiyun Zheng, Qitong Su, Dongli Lu, Shiqin Wu, Zhenghua Jiang, Zhaochun Wu   +6 more
doaj   +1 more source

Gigantic hip mass as the initial presentation of hyperphosphatemic familial tumoral calcinosis [PDF]

Archive of Oncology
Introduction: Hyperphosphatemic familial tumoural calcinosis (HFTC) is a rare autosomal recessive disorder characterised by ectopic calcium phosphate deposition around the joints due to mutations affecting phosphate regulation.
Krishnan Surya, Murali Anjali, Keechilat Pavithran   +2 more
doaj   +1 more source

Effect of pan-caspase inhibitor z-VAD in preventing apoptosis caused by simulated hypophosphatemia and hyperphosphatemia.

, 2013
To further define the role of inorganic phosphate on human umbilical vein endothelial cell apoptosis, a pan-caspase inhibitor z-VAD (40 uM) was added to the medium containing various concentrations of phosphate.
Ting Ye (346594), Xin J. Zhou (305431), Chandra Mohan (157054), Nosratola D. Vaziri (346596), Ai Peng (346588), Dinesh Rakheja (346590), Tianfu Wu (156995), Jiankun Zhu (346592), Zhihong Liu (112690), Caihong Zeng (306421), Jack Hutcheson (38669)   +10 more
core   +1 more source

Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients [PDF]

, 2013
Elevated serum phosphorus is associated with higher death risk in hemodialysis patients. Previous studies have suggested that both higher serum parathyroid hormone (PTH) level and higher dietary protein intake may contribute to higher serum phosphorus ...
Kovesdy, Csaba P, Lau, Wei Ling, Sim, John J, Kalantar-Zadeh, Kamyar, Streja, Elani, Nissenson, Allen R, Goldstein, Leanne, Molnar, Miklos Z   +7 more
core   +1 more source

Patient Empowerment in the Management of Hyperphosphatemia

, 2007
Despite advances in dialysis technology and an increasing variety of effective phosphate binders (PB) target phosphate levels are achieved in only a minority of ESRD patients.
S. Hoechst, I. Landthaler, M. K Kuhlmann
core   +1 more source